| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11029321 | Lung Cancer | 2018 | 31 Pages |
Abstract
Our results supported the composite endpoint for objective response evaluation of LM was valid, suggested LM outweighed peripheral lesions on the impact to patient survival, and emphasized the urge and promise of development of CNS-penetrant targeted therapies to improve clinical outcome of NSCLC-LM patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yan Xu, Min Hu, Meizhuo Zhang, Wei Zhong, Xiaolu Yin, Yun Sun, Minjiang Chen, Jing Zhao, Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Li Zhang, Ji Li, Hongzhi Guan, Zhenfan Yang, Mengzhao Wang,